Skip to main content

Psychedelic Treatments

MDMA-assisted psychotherapy for the treatment of alcohol use disorder was found to improve psychosocial functioning with no unexpected adverse events in a clinical trial conducted by London-based Awakn Life Sciences.
With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.
Psychedelic medicine biotech firm MindMed has announced it has begun a study for a technology that could shorten and stop the effects of an LSD trip during therapy, which could create an “emergency shut-off switch” for psychedelic-assisted therapy.
The Multidisciplinary Association for Psychedelic Studies (MAPS) and Fireside Project, a not-for-profit psychedelic support services organization, announced plans to launch a national support line to help individuals having difficult psychedelic experiences and those who want to gain a better understanding of past psychedelic experiences.
In an interview with The Sun magazine, Psych Congress co-chair Charles Raison, MD, discussed the challenge of depression’s myriad symptoms and the therapeutic effects of various psychedelics in treatment.
With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.
Back to Top